KPV

A tripeptide fragment investigated in preclinical cellular research.

View KPV in the store

Molecular Profile

Type
Synthetic peptide (tripeptide)
Molecular formula
C16H30N4O4
Molecular weight
342.43 g/mol
CAS number
67727-97-3
Amino acids
3
Sequence
Lys-Pro-Val (KPV)
Modification
Free termini; C-terminal tripeptide of alpha-MSH (residues 11-13).

Mechanism & Target Class

The C-terminal tripeptide (Lys-Pro-Val) of alpha-MSH. It is studied in cellular research in the context of the PepT1 (SLC15A1) peptide transporter and NF-kB / MAPK signaling.

Storage & Handling

Lyophilized
-20°C; protect from light and moisture; ~24 months.
Handling
Small soluble tripeptide; protect from moisture; aliquot.

Primary Database

PubChem CID 125672 ↗

References (21)

  1. Reviews

    1

    Gravina AG, et al. (2023). Cells

    DOI: 10.3390/cells12141889

  2. 2

    Brzoska T, et al. (2010). Adv Exp Med Biol

    PubMed 21222263

  3. 3

    Brzoska T, et al. (2008). Endocr Rev

    DOI: 10.1210/er.2007-0027PubMed 18612139

  4. 4

    Luger TA, Brzoska T. (2007). Ann Rheum Dis

    DOI: 10.1136/ard.2007.079780PubMed 17934097

  5. 5

    Luger TA, et al. (2003). Ann N Y Acad Sci

    DOI: 10.1111/j.1749-6632.2003.tb03172.xPubMed 12851308

  6. 6

    Dinparastisaleh R, Mirsaeidi M. (2021). Pharmaceuticals (Basel)

    DOI: 10.3390/ph14010045PubMed 33430064

  7. 7

    Adnan SB, et al. (2025). Int J Med Sci

    DOI: 10.7150/ijms.118118PubMed 41209547

  8. Primary research

    8

    Sung J, et al. (2025). Tissue Cell

    PubMed 40073467

  9. 9

    Preclinical delivery study (2024). Front Pharmacol

    DOI: 10.3389/fphar.2024.1442876

  10. 10

    Preclinical hydrogel study (2021). PubMed

    PubMed 34547895

  11. 11

    Pawar K, et al. (2017). J Pharm Sci

    DOI: 10.1016/j.xphs.2017.03.017PubMed 28343991

  12. 12

    Xiao B, et al. (2017). Mol Ther

    DOI: 10.1016/j.ymthe.2016.11.020PubMed 28143741

  13. 13

    Viennois E, et al. (2016). Cell Mol Gastroenterol Hepatol

    DOI: 10.1016/j.jcmgh.2016.01.006PubMed 27458604

  14. 14

    Laroui H, et al. (2010). Gastroenterology

    DOI: 10.1053/j.gastro.2009.11.003PubMed 19909746

  15. 15

    Dalmasso G, et al. (2008). Gastroenterology

    DOI: 10.1053/j.gastro.2007.10.026

  16. 16

    Kannengiesser K, et al. (2008). Inflamm Bowel Dis

    DOI: 10.1002/ibd.20334PubMed 18092346

  17. 17

    Catania A, et al. (2005). J Pept Res

    DOI: 10.1111/j.1399-3011.2005.00265.xPubMed 15946192

  18. 18

    Elliott RJ, et al. (2004). J Invest Dermatol

    DOI: 10.1111/j.0022-202X.2004.22404.xPubMed 15102092

  19. 19

    Getting SJ, et al. (2003). J Pharmacol Exp Ther

    DOI: 10.1124/jpet.103.051623PubMed 12750433

  20. 20

    Cutuli M, et al. (2000). J Leukoc Biol

    DOI: 10.1002/jlb.67.2.233PubMed 10670585

  21. 21

    Shao W, et al. (2022). Biomater Sci

    DOI: 10.1039/d1bm01466hPubMed 34846053